ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 2000, the company has established itself as a leader in the development and manufacturing of high-quality generic and branded prescription medications. With a focus on complex formulations, ANI Pharmaceuticals serves a diverse range of therapeutic areas, including pain management, oncology, and anti-infectives. The company’s commitment to innovation is evident in its extensive portfolio of products, which includes unique formulations that address unmet medical needs. ANI Pharmaceuticals has achieved significant milestones, including strategic acquisitions that have expanded its operational footprint across major regions in the US. With a strong market position and a dedication to quality, ANI Pharmaceuticals continues to make a meaningful impact in the healthcare landscape.
DitchCarbon Score
How does ANI Pharmaceuticals, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
ANI Pharmaceuticals, Inc.'s score of 25 is lower than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
ANI Pharmaceuticals, Inc.'s reported carbon emissions
ANI Pharmaceuticals, Inc., headquartered in the US, currently does not have publicly available data regarding its carbon emissions, as no specific emissions figures have been reported. Additionally, there are no documented reduction targets or climate pledges outlined by the company. This absence of data suggests that ANI Pharmaceuticals may still be in the early stages of formalising its climate commitments or reporting practices. As the pharmaceutical industry increasingly prioritises sustainability, ANI Pharmaceuticals may need to consider establishing clear emissions reduction goals and strategies to align with industry standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
ANI Pharmaceuticals, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
